Which Organ Does Melatonin Affect? 

Most people think of melatonin as a sleep supplement — something that acts on the brain at bedtime. The science tells a more surprising story. Research published in Endotext confirms that melatonin can act at almost all levels of the organism, with receptors identified in over a dozen tissues and organs. Understanding where melatonin works — and how — gives you a clearer picture of what you're actually taking and why the delivery method matters.

Table of Contents

1. The Pineal Gland: Where Melatonin Is Made
2. The Brain: How the SCN Controls the Clock
3. The Gut: The Overlooked Second Source
4. The Immune System: Melatonin's Overlooked Role
5. The Eyes: A Two-Way Relationship
6. Neuroprotection: Melatonin's Broader Brain Role
7. Getting Melatonin Where It Needs to Go
8. Frequently Asked Questions
9. Conclusion

1. The Pineal Gland: Where Melatonin Is Made

The pineal gland sits at the geometric center of the brain — a pea-sized structure weighing roughly 100–150 mg — and serves as melatonin's primary factory. According to Endotext's physiology reference, the pineal gland's main function is to receive information about the light-dark cycle from the environment and translate it into melatonin output. It produces melatonin in a highly predictable rhythm: levels rise steeply within the first hour or two after darkness, peak between 2–4 AM in most adults, and fall before dawn.

The pineal gland's central role as melatonin's origin is confirmed by a simple experiment: remove it, and circulating melatonin drops to near-undetectable levels. Post-pinealectomy research shows that while melatonin is produced in other tissues (the gut, retina, skin, bone marrow), these extrapineal sources contribute little to blood concentrations in mammals under normal conditions. The pineal gland is not just one of several sources — it is the dominant source for systemic hormone levels.

Pineal function naturally declines with age. Calcification of the pineal gland — a process that affects the majority of adults over 60 — reduces its capacity to produce melatonin. This age-related decline in pineal output is associated with disrupted sleep patterns, increased nighttime wakefulness, and reduced circadian signal strength. For people considering melatonin supplementation, this biological reality is part of the rationale: the pineal gland produces less as we age, and supplementing the deficit is a physiologically grounded strategy.

2. The Brain: How the SCN Controls the Clock

Melatonin doesn't just come from the brain — it feeds back into the brain as a timing signal. The suprachiasmatic nucleus (SCN) of the hypothalamus is described by StatPearls' neuroanatomy reference as the central pacemaker of the circadian timing system. The SCN consists of approximately 10,000 neurons per nucleus on each side of the third ventricle. During darkness, the SCN sends norepinephrine signals via the sympathetic nervous system to the pineal gland — stimulating melatonin production. Once released, melatonin feeds back to the SCN via MT1 and MT2 receptors, helping the clock maintain its 24-hour rhythm.

The practical consequence of this feedback loop is a predictable rise in sleep propensity. A review in the British Journal of Pharmacology found that the sharp increase in sleep propensity at night typically occurs approximately 2 hours after the onset of endogenous melatonin production. This 2-hour lag matters for supplementation: taking melatonin too close to your intended bedtime may not align with your body's receptor sensitivity window. The optimal timing window — generally 30–90 minutes before bed for most adults — is informed by this receptor physiology.

Melatonin's action on the brain also extends to circadian phase-shifting. A 2021 review in the Handbook of Clinical Neurology describes melatonin as a potent chronobiotic — a substance capable of influencing the phase and period of the circadian clock. The most convincing evidence comes from blind individuals who lack light input for their biological clock: daily exogenous melatonin entrains their sleep-wake cycle to a 24-hour cycle. This property underpins melatonin's clinical use in jet lag, shift work, and non-24-hour sleep disorder.

3. The Gut: The Overlooked Second Source

The gut's role in melatonin biology is one of the most surprising findings in modern sleep science. Research in the World Journal of Gastroenterology established that the gut contains at least 400 times more melatonin than the pineal gland. This melatonin is produced by enterochromaffin cells in the gut mucosa and operates independently of the light-dark cycle — its release is driven by food intake rather than darkness. The GI tract contains MT1, MT2, and MT3 melatonin receptors that regulate motility, inflammation, and pain.

Gut melatonin appears to protect the intestinal lining. A review in Digestive Diseases and Sciences found that GI melatonin acts as an endocrine, paracrine, and autocrine hormone — influencing the regeneration and function of the gut epithelium, supporting the gut immune system, and reducing the tone of smooth muscle in the gastrointestinal tract. Unlike pineal melatonin, gut melatonin levels remain stable after pinealectomy, confirming an independent local production system. After oral administration of tryptophan, melatonin levels in blood increase substantially — in both intact and pinealectomised animals — pointing to the gut as the major producer of post-meal melatonin.

For supplement users, this matters in one specific way: oral melatonin first encounters the gut before reaching the bloodstream. Standard tablet forms must survive the digestive process, and research consistently shows their bioavailability sits at roughly 15% of the administered dose. Liposomal delivery — used in BioAbsorb's formulation — encapsulates melatonin in a lipid shell that protects it during digestion and facilitates absorption through gut wall membranes. The result, per BioAbsorb's liposomal melatonin, is an estimated bioavailability of 80–95% versus 15–20% for conventional tablets.

4. The Immune System: Melatonin's Overlooked Role

Melatonin's reach into the immune system is substantial and well-documented. A comprehensive review in the International Journal of Molecular Sciences found that removing the pineal gland causes pronounced shrinkage of both primary and secondary lymphoid organs — including the thymus and spleen — accompanied by measurable decreases in cellular immune function. Melatonin receptors have been identified in multiple immune organs and on lymphocytes themselves. Melatonin modulates a wide range of physiological functions with pleiotropic effects on the immune system — meaning it affects immune function through many simultaneous mechanisms rather than a single pathway.

The hormone appears to regulate both inflammatory and anti-inflammatory responses depending on context. Research published in Frontiers in Neuroendocrinology found that high melatonin levels promote several immune system parameters while low levels suppress them. In practice, this circadian relationship means that the immune system is not static — it ramps up during sleep, when melatonin is high, and pulls back during the waking hours of the day. Sleep deprivation, which suppresses melatonin, doesn't just make you tired — it measurably alters immune function.

• Melatonin receptors found in lymphoid organs, B and T lymphocytes, monocytes, and natural killer cells
• Pinealectomy in animal models reduces immune organ mass and cellular immune function within weeks
• Melatonin promotes Th1-type immune responses by enhancing IL-2 and IL-12 production
• Age-related melatonin decline correlates with immunosenescence — the gradual weakening of immune responsiveness over time

The circadian link between melatonin and immune function also has clinical relevance for vaccination and illness. Immune responses to pathogens and vaccines show time-of-day variation. This is not incidental — it reflects melatonin's role as one of the body's main chronobiological signals, coordinating the timing of immune activity alongside sleep and repair processes.

5. The Eyes: A Two-Way Relationship

The relationship between melatonin and the eyes operates in two directions. The eyes are the entry point for the light signals that suppress melatonin production — specialized retinal ganglion cells containing melanopsin detect light and relay information to the SCN via the retinohypothalamic tract. This light-sensing function is how the pineal gland knows when it's day or night. But the retina also produces melatonin locally. Research in Progress in Retinal and Eye Research confirmed that melatonin in the eye is involved in modulating important retinal functions, including the electroretinogram (ERG) — the electrical activity of retinal cells in response to light.

Melatonin receptors in the eye — specifically MT1 and MT2 subtypes — regulate intraocular pressure and help coordinate local circadian rhythms in vision. Intraocular pressure follows a circadian pattern in healthy eyes, peaking early morning and falling during the day, and melatonin appears to influence this rhythm. The same review noted that melatonin administration may represent a useful approach to preventing and treating glaucoma — a condition affecting roughly 80 million people worldwide — via its influence on intraocular pressure regulation.

There is also evidence that melatonin offers protective effects for retinal cells including pigment epithelial cells, photoreceptors, and ganglion cells. A series of studies have implicated melatonin in the pathogenesis of age-related macular degeneration (AMD), a leading cause of vision loss in adults over 50. Whether supplemental melatonin can meaningfully protect retinal health in humans requires further clinical study — but the receptor biology and early data are sufficiently compelling to warrant ongoing research.

6. Neuroprotection: Melatonin's Broader Brain Role

Beyond sleep regulation, melatonin exerts direct neuroprotective effects in the brain. A 2024 review in the International Journal of Molecular Sciences concluded that melatonin and its metabolites have an anti-aging capacity, retarding healthy brain aging and the development of neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, and ALS. The primary mechanism is antioxidant: melatonin is a potent free-radical scavenger capable of crossing the blood-brain barrier and accumulating in mitochondria — the site where most oxidative damage originates.

Mitochondrial protection is particularly relevant to brain aging. At a dose of just 100 nanomolar, melatonin achieves intramitochondrial concentrations approximately 100 times greater than plasma levels — meaning it concentrates precisely where oxidative damage is most damaging. Research in Translational Psychiatry confirmed that melatonin receptors (MT1) are present on mitochondrial outer membranes, where they inhibit stress-mediated cytochrome C release — a precursor to cell death and neuroinflammation.

Melatonin levels decline measurably with age — a pattern that appears across pineal and tissue measurements in most older adults. This decline is associated with increased oxidative stress, disrupted sleep architecture, and heightened risk of the cognitive changes associated with aging. While melatonin supplementation is not a proven treatment for neurodegenerative disease, the mechanistic case for its protective role in the aging brain is supported by a growing body of preclinical and early clinical evidence.

7. Getting Melatonin Where It Needs to Go

Understanding which organs melatonin affects raises an obvious follow-on question: how much of a standard supplement actually reaches those organs? The bioavailability problem with oral melatonin is significant. Standard tablets and capsules typically deliver roughly 15% of the stated dose into circulation — the rest is degraded in the stomach or metabolised by the liver before it reaches target tissues. For a receptor in the gut, the retina, or the immune system to receive melatonin, it first needs to survive the route from mouth to bloodstream.

BioAbsorb Liposomal Liquid Melatonin addresses this with liposomal encapsulation — a delivery method that wraps melatonin in a phospholipid shell structurally similar to the body's own cell membranes. This shell protects melatonin during digestion and facilitates absorption through the intestinal wall, achieving an estimated bioavailability of 80–95%. The formulation contains 5mg per full dropper (1ml) via a graduated dropper that allows precise increments as low as ~0.5mg — useful for users who want to start low and titrate to their minimum effective dose. Onset is typically 15–30 minutes versus 60–90 minutes for conventional tablets.

BioAbsorb is manufactured in a Health Canada-approved, GMP-certified facility in Canada. The melatonin formulation is non-GMO, vegan, gluten-free, and free of artificial flavours or colours. Every batch is third-party tested, with a Certificate of Analysis (COA) available on request. At $29.99 for 100ml (100 servings), the cost per dose is comparable to standard tablet forms while delivering a meaningfully higher proportion of the stated dose into circulation. For users whose primary interest is organ-level effectiveness — not just a number on a label — the delivery format is not a detail; it is the core of the value proposition.

Frequently Asked Questions

Does melatonin primarily affect the brain?

The brain is where melatonin is best understood — specifically through its action on the suprachiasmatic nucleus and the pineal gland — but "primarily" would be misleading. Published endocrinology references confirm that melatonin receptors have been found in the gut, immune organs, retina, cardiovascular tissues, bone marrow, skin, and reproductive system. The brain is the most studied site, not necessarily the most impacted one — the gut, for instance, contains 400 times more melatonin than the pineal gland.

Which organ produces the most melatonin in the body?

The gut produces far more melatonin by total quantity — at least 400 times more than the pineal gland — but the pineal gland dominates circulating blood melatonin levels. The distinction matters: gut melatonin acts locally on the GI tract, regulated by food intake rather than light. Pineal melatonin enters the bloodstream and serves as the body's systemic darkness signal. After pinealectomy, blood melatonin drops to near-zero despite the gut's large local reserves.

What happens to the immune system if melatonin is low?

Animal studies involving pinealectomy show a consistent pattern: removal of the pineal gland causes measurable shrinkage of lymphoid organs and reduced immune function within weeks. Research in the International Journal of Molecular Sciences found that low melatonin suppresses multiple immune system parameters, while higher nighttime levels promote immune activity. This is consistent with the well-established observation that sleep deprivation — which suppresses melatonin — impairs immune response.

Can melatonin affect eye health?

There is growing evidence that melatonin receptors in the retina serve a functional role in ocular health. Research in Progress in Retinal and Eye Research found that melatonin may protect retinal pigment epithelial cells, photoreceptors, and ganglion cells from oxidative damage. Some evidence suggests a potential role in preventing or treating glaucoma through regulation of intraocular pressure, which affects approximately 80 million people worldwide. This remains an active research area and is not yet the basis for clinical treatment recommendations.

Does melatonin cross the blood-brain barrier?

Yes — melatonin's chemical structure makes it highly capable of crossing the blood-brain barrier. It is amphiphilic, meaning it dissolves in both water and fat, which allows it to diffuse through most cell membranes. StatPearls notes that melatonin's half-life is approximately 30 minutes and it is cleared mostly through the liver. Its ability to enter the brain freely is what allows it to act directly on the SCN and on brain mitochondria — the same property that makes bioavailability in the bloodstream a prerequisite for central nervous system action.

Does supplemental melatonin reach all these organs?

Only the melatonin that reaches the bloodstream can act systemically on organs including the brain, immune system, and eyes. Standard tablets have an absorption rate of approximately 15–20%, meaning much of what you take is lost before it enters circulation. Liposomal formats like BioAbsorb Liposomal Melatonin are designed to improve this to an estimated 80–95% bioavailability — so more of the stated dose actually reaches the bloodstream and becomes available to target organs.

Conclusion

The answer to "which organ does melatonin affect?" is genuinely complex: the pineal gland produces it, the brain's SCN uses it to run the clock, the gut hosts 400 times more of it than the pineal gland, the immune system depends on it, and the eyes both regulate and are regulated by it. This breadth of action is why melatonin has attracted serious research attention well beyond sleep science. If you're considering melatonin supplementation, the organ-level science points to one practical consideration: delivery format determines how much actually arrives. Explore BioAbsorb Liposomal Melatonin for a format designed to close the gap between the dose on the label and the dose your organs receive.

Research References

1. Physiology of the Pineal Gland and Melatonin. Endotext, NCBI Bookshelf (NBK550972, 2022). Comprehensive review of pineal gland function, melatonin synthesis and secretion, receptor biology, extrapineal synthesis sites, and clinical conditions related to melatonin disruption.
2. Melatonin. StatPearls, NCBI Bookshelf (NBK534823, 2024). Clinical reference covering melatonin's interaction with the SCN and retina via MT1 and MT2 receptors; AAFP recognition of melatonin as first-line therapy for insomnia; blood-brain barrier crossing; hepatic clearance and half-life.
3. Distribution, Function and Physiological Role of Melatonin in the Lower Gut. World Journal of Gastroenterology, Vol. 17 (2011). Established that the gut contains at least 400 times more melatonin than the pineal gland; reviewed MT1, MT2, and MT3 receptor roles in GI motility, inflammation, and pain; confirmed local gut synthesis independent of the pineal.
4. Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance. Digestive Diseases and Sciences, Vol. 47 (2002). Identified GI melatonin's endocrine, paracrine, and autocrine actions on gut epithelium, gut immune system, and smooth muscle tone; found gut melatonin release is tied to food intake, not light-dark cycle.
5. New Perspectives on the Role of Melatonin in Human Sleep, Circadian Rhythms and Their Regulation. British Journal of Pharmacology, Vol. 175 (2018). Identified the approximately 2-hour lag between melatonin onset and peak sleep propensity; described the SCN-activated, light-inhibited mechanism that conveys darkness signals to the brain and induces night-state physiology.
6. Melatonin: Buffering the Immune System. International Journal of Molecular Sciences, Vol. 14 (2013). Systematic review confirming pinealectomy causes lymphoid organ shrinkage and reduced immune function; described melatonin receptors in lymphoid organs and lymphocytes; reviewed pleiotropic immune regulation mechanisms.
7. Human Pineal Physiology and Functional Significance of Melatonin. Frontiers in Neuroendocrinology, Vol. 25 (2004). Reviewed evidence for melatonin receptors in lymphoid organs, melatonin's mild hypothermic and hypotensive effects, and its putative role in human reproductive physiology via puberty onset associations.
8. Neuroanatomy, Nucleus Suprachiasmatic. StatPearls, NCBI Bookshelf (NBK546664, 2023). Described the SCN's structure (~10,000 neurons per nucleus), its role as the central circadian pacemaker, and its polysynaptic projections to the pineal gland that trigger nocturnal melatonin synthesis via norepinephrine.
9. The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging. International Journal of Molecular Sciences, Vol. 25 (2024). Reviewed evidence that melatonin and its metabolites have anti-aging capacity for the brain, including protection against Alzheimer's, Parkinson's, Huntington's disease, and MS through mitochondrial antioxidant mechanisms.
10. Circadian Rhythms in the Eye: The Physiological Significance of Melatonin Receptors in Ocular Tissues. Progress in Retinal and Eye Research, Vol. 26 (2007). Confirmed melatonin receptors in retina, identified melatonin's role in modulating the ERG and retinal cell protection, and proposed a role in glaucoma treatment via intraocular pressure regulation.
11. Melatonin and the Circadian System: Keys for Health with a Focus on Sleep. Handbook of Clinical Neurology, Vol. 179 (2021). Described melatonin as a potent chronobiotic acting on the SCN via MT1 and MT2 receptors; reviewed evidence from blind individuals showing exogenous melatonin entrains sleep-wake cycles to a 24-hour period.
12. Melatonin's Neuroprotective Role in Mitochondria and Its Potential as a Biomarker in Aging. Translational Psychiatry (2021). Documented MT1 receptors on mitochondrial outer membranes; found melatonin achieves intramitochondrial concentrations approximately 100 times greater than plasma levels; reviewed melatonin's role in inhibiting cytochrome C release and neurodegeneration.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.